Enanta Pharmaceuticals, Inc. (ENTA) financial statements (2021 and earlier)

Company profile

Business Address 500 ARSENAL STREET
WATERTOWN, MA 02472
State of Incorp. DE
Fiscal Year End September 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments386387335309224210145
Cash and cash equivalents55875164661722
Short-term investments331300284245158194123
Receivables32235167111316
Deferred tax assets   1
Other undisclosed current assets2827154498
Total current assets:446437402380238232171
Noncurrent Assets
Operating lease, right-of-use asset87 
Property, plant and equipment89118886
Long-term investments and receivables18336516703264
Long-term investments18336516703264
Restricted cash and investments1111111
Deferred income tax assets00 
Other noncurrent assets0000   
Deferred tax assets, net81085
Other undisclosed noncurrent assets  11    
Total noncurrent assets:35498834894975
TOTAL ASSETS:481486490414327281246
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities182023162188
Accounts payable6675432
Accrued liabilities12141610854
Employee-related liabilities      2
Taxes payable   19 1
Debt      0
Other undisclosed current liabilities54    (2)
Total current liabilities:232423162187
Noncurrent Liabilities
Long-term debt and lease obligation44    1
Capital lease obligations   1
Operating lease, liability44 
Liabilities, other than long-term debt1133223
Accounts payable and accrued liabilities      1
Asset retirement obligations      0
Liability for uncertainty in income taxes      0
Other liabilities1133222
Other undisclosed noncurrent liabilities112221(0)
Total noncurrent liabilities:6655433
Total liabilities:29312721251110
Stockholders' equity
Stockholders' equity attributable to parent, including:452456462394302270236
Common stock0000000
Additional paid in capital332327298277256242230
Accumulated other comprehensive income (loss)010(0)(0)00
Retained earnings11912816411745286
Warrants and rights outstanding      1
Other undisclosed stockholders' equity attributable to parent      (1)
Total stockholders' equity:452456462394302270236
TOTAL LIABILITIES AND EQUITY:481486490414327281246

Income statement (P&L) ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
Revenues10212220520710388161
Revenue, net385836
Cost of revenue
(Cost of Goods and Services Sold)
      (0)
Gross profit:10212220520710388161
Operating expenses(168)(164)(168)(118)(78)(57)(50)
Other undisclosed operating income      14
Operating income (loss):(67)(42)37882531124
Nonoperating income5795221
Investment income, nonoperating 0 (0)221
Other nonoperating income2      
Interest and debt expense    (0)(0)(0)
Income (loss) from continuing operations before equity method investments, income taxes:(62)(35)46932733125
Other undisclosed income from continuing operations before income taxes    000
Income (loss) from continuing operations before income taxes:(62)(35)46932733125
Income tax expense (benefit)4(1)1(21)(9)(11)(46)
Net income (loss) available to common stockholders, diluted:(58)(36)4672182279

Comprehensive Income ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
Net income (loss):(58)(36)4672182279
Other comprehensive income (loss)   (0)(0)(0)0
Comprehensive income (loss):(58)(36)4672182279
Other undisclosed comprehensive income, net of tax, attributable to parent011    
Comprehensive income (loss), net of tax, attributable to parent:(58)(35)4772182279

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: